Understanding how deletions of chromosome 7 affect blood cell formation in certain blood disorders.
Defining the Pathogenesis of Del(7q) in Hematopoietic Stem Cells
This study is looking at how missing pieces of chromosome 7 might contribute to blood disorders like myelodysplastic syndromes and leukemia, with the goal of finding better treatments for patients like you.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11058422 on NIH RePORTER |
What this research studies
This research investigates the role of deletions in chromosome 7, specifically del(7q), in the development of myelodysplastic syndromes (MDS) and acute leukemia. By studying hematopoietic stem cells, the research aims to uncover the genetic mechanisms that lead to ineffective blood cell production and increased cancer risk. The approach includes creating animal models to better understand the disease and identify potential new therapies. Patients may benefit from insights that could lead to improved treatment options for these serious blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myelodysplastic syndromes or acute leukemia, particularly those with chromosome 7 deletions.
Not a fit: Patients with blood disorders not associated with chromosome 7 abnormalities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies for patients with myelodysplastic syndromes and acute leukemia.
How similar studies have performed: Previous research has shown promise in understanding genetic abnormalities in blood disorders, making this approach a continuation of ongoing efforts in the field.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Jotte, Matthew — University of Chicago
- Study coordinator: Jotte, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.